retatrutide safety If isn't FDA approved yet, how is everyone already taking it? 👀⁠ ⁠ On this episode of “The Beauty Authority,” board-certified endocrinologist @drrekhakumar explains why the next-generation weight-loss drug has become More data on Retatrutide dropped

Metabolism & Elimination Limited characterization of specific metabolic pathways has been published for both peptides: CJC-1295 (NO DAC): Peptidase-mediated degradation represents primary metabolic pathway Four amino acid substitutions provide enhanced resistance to dipeptidyl peptidase-IV Metabolites and degradation products not fully characterized in published literature Clearance from circulation within hours despite sustained pharmacodynamic effects Ipamorelin: Clearance of 0.078 L/h/kg in human pharmacokinetic studies Rapid elimination from plasma following distribution phase Metabolic pathways likely involve proteolytic cleavage at peptide bonds No significant accumulation observed with repeated dosing in animal models A notable pharmacokinetic-pharmacodynamic disconnect exists: despite relatively short plasma half-lives (30 minutes to 2 hours), growth hormone secretory effects persist for 6+ hours, suggesting either active metabolites, tissue retention, or persistent receptor signaling cascade activation

Global Expansion: European health care markets are growing in their role in adopting obesity treatment as part of a larger metabolic disease control policy

While liraglutide and semaglutide work through the same GLP-1 receptor pathway, they differ in how long they act, how often theyre taken, and what theyre approved to treat

Sermorelin has held a more stable position due to its prior FDA approval

Another clinical trial found that elevated GH levels significantly improved nitrogen retention , a key factor in muscle growth